US$ 21.96
bpc 157 multiple sclerosis clinical trial humans Stable Gastric Pentadecapeptide as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats BPC-157 – No Proof Required!
Description
People actively managing blood sugar with medication should monitor more frequently during peptide use and communicate with their healthcare provider about any changes

In particular, tell your provider if you have or have a past history of: Type 1 or type 2 diabetes Thyroid cancer Pancreatitis Kidney disease Diabetic retinopathy Depression Suicidal thoughts or behavior Ileus Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding

This blend contains both peptides co-lyophilized in one vial at a fixed 1:1 ratio (5 mg + 5 mg), reconstituted together for combined experimental work
Every bottle ships with the in-house release sheet for the lot on the label HPLC-UV purity and ESI-MS identity, keyed to that lot code
